Liang Xie
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 15
- Protease and Inhibitor Mechanisms 8
- Genetics top 1%
- Nephrology top 1%
- Molecular Biology top 2%
- RNA modifications and cancer 9
- Angiogenesis and VEGF in Cancer 9
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 8
-
- Esophageal Cancer Research and Treatment 9
-
- Congenital Heart Disease Studies 8
-
- Pulmonary Hypertension Research and Treatments 8
- Co-authors
- Raghu KalluriQuan YuanScott PotentaElisabeth M. ZeisbergMichael ZeisbergPia NybergMengyuan WangQianming Chen
- Cited by
- Cancer ResearchGeneticsNephrology
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (5 papers)Journal of Clinical Investigation (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Liang Xie
161 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 1.5k
- Genetics 656
- Nephrology 437
- Molecular Biology 3.6k
- Immunology and Allergy 309
Countries citing papers authored by Liang Xie
This map shows the geographic impact of Liang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Xie more than expected).
Fields of papers citing papers by Liang Xie
This network shows the impact of papers produced by Liang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Xie. The network helps show where Liang Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 28 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 14 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 28 | |
| 10 | 2021 | 21 | |
| 11 | 2020 | 28 | |
| 12 | 2020 | 31 | |
| 13 | 2018 | 169 | |
| 14 | 2018 | 34 | |
| 15 | 2018 | 69 | |
| 16 | 2018 | 38 | |
| 17 | [Prospective study on the isolated ventricular septal defect in fetus]. | 2015 | 3 |
| 18 | [Mechanisms for reversal of pulmonary hypertension by rapamycin in rats]. | 2015 | 1 |
| 19 | 2009 | 125 | |
| 20 | Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblastsbreakdown → | 2007 | 784 |
About Liang Xie
Liang Xie is a scholar working on Cancer Research, Immunology and Allergy and Periodontics, having authored 166 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (15 papers), RNA modifications and cancer (9 papers), Esophageal Cancer Research and Treatment (9 papers), Angiogenesis and VEGF in Cancer (9 papers), Cell Adhesion Molecules Research (8 papers), Protease and Inhibitor Mechanisms (8 papers), Congenital Heart Disease Studies (8 papers) and Pulmonary Hypertension Research and Treatments (8 papers). The work is most often cited by research in Cancer Research (1.5k citations), Genetics (656 citations) and Nephrology (437 citations). Liang Xie has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Raghu Kalluri, Quan Yuan, Scott Potenta, Elisabeth M. Zeisberg, Michael Zeisberg, Pia Nyberg, Mengyuan Wang, Qianming Chen, Hikaru Sugimoto and Xu Cao. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.